FI864260A - Flavonderivat. - Google Patents
Flavonderivat. Download PDFInfo
- Publication number
- FI864260A FI864260A FI864260A FI864260A FI864260A FI 864260 A FI864260 A FI 864260A FI 864260 A FI864260 A FI 864260A FI 864260 A FI864260 A FI 864260A FI 864260 A FI864260 A FI 864260A
- Authority
- FI
- Finland
- Prior art keywords
- flavonderivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22578/85A IT1190405B (it) | 1985-10-22 | 1985-10-22 | Derivati del flavone |
| IT2257885 | 1985-10-22 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI864260A0 FI864260A0 (fi) | 1986-10-21 |
| FI864260A true FI864260A (fi) | 1987-04-23 |
| FI89167B FI89167B (fi) | 1993-05-14 |
| FI89167C FI89167C (fi) | 1993-08-25 |
Family
ID=11198039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI864260A FI89167C (fi) | 1985-10-22 | 1986-10-21 | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara flavonyl-1,4-dihydropyridinderivat |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4806534A (fi) |
| EP (1) | EP0223744B1 (fi) |
| JP (1) | JPH0772186B2 (fi) |
| KR (1) | KR910009269B1 (fi) |
| CN (1) | CN86107544A (fi) |
| AR (1) | AR243883A1 (fi) |
| AT (1) | ATE73453T1 (fi) |
| AU (1) | AU596382B2 (fi) |
| CA (1) | CA1330994C (fi) |
| DE (1) | DE3684244D1 (fi) |
| DK (1) | DK169408B1 (fi) |
| EG (1) | EG18109A (fi) |
| ES (1) | ES2002425A6 (fi) |
| FI (1) | FI89167C (fi) |
| GR (1) | GR862546B (fi) |
| HU (1) | HU202863B (fi) |
| IE (1) | IE58330B1 (fi) |
| IL (1) | IL80229A0 (fi) |
| IT (1) | IT1190405B (fi) |
| NO (1) | NO167570C (fi) |
| NZ (1) | NZ217964A (fi) |
| PH (1) | PH22766A (fi) |
| PT (1) | PT83604B (fi) |
| SG (1) | SG55192G (fi) |
| TN (1) | TNSN86144A1 (fi) |
| ZA (1) | ZA867941B (fi) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912223A (en) * | 1988-01-28 | 1990-03-27 | Nelson Research & Development Co. | 1,4-Dihydropyridines |
| US5580751A (en) * | 1990-09-14 | 1996-12-03 | Carlsberg A/S | Process for the preparation of C-terminally amidated peptides |
| US5244602A (en) * | 1990-12-03 | 1993-09-14 | Ppg Industries, Inc. | Photochromic naphthopyrans |
| DE4321030A1 (de) * | 1993-06-24 | 1995-01-05 | Bayer Ag | 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel |
| SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| KR100392468B1 (ko) * | 2000-09-18 | 2003-07-22 | 주식회사 엘지생명과학 | 사이클린 의존 키나아제의 저해제로서 유용한3-히드록시크로멘-4-온 유도체 |
| MXPA03006250A (es) | 2001-01-16 | 2003-09-22 | Astrazeneca Ab | Compuestos heterociclicos terapeuticos. |
| DE102005034267A1 (de) * | 2005-07-22 | 2007-01-25 | Bayer Healthcare Ag | 4-Chromenonyl-1,4-dihydropyridine und ihre Verwendung |
| DE102005034264A1 (de) * | 2005-07-22 | 2007-02-01 | Bayer Healthcare Ag | 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung |
| CN103254122B (zh) * | 2013-06-19 | 2015-04-22 | 湖南师范大学 | 一种心血管药物尼伐地平的制备方法 |
| AR121719A1 (es) | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| JP7308369B2 (ja) | 2021-05-03 | 2023-07-13 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド３－キナーゼ（ｐｉ３ｋ）のアロステリッククロメノン阻害剤 |
| EP4347040A1 (en) | 2021-05-27 | 2024-04-10 | Petra Pharma Corporation | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2921070A (en) * | 1957-11-05 | 1960-01-12 | Recordati Lab Farmacologico S | Basic esters of 3-methylflavone-8-carboxylic acid |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3311005A1 (de) * | 1983-03-25 | 1984-09-27 | Bayer Ag, 5090 Leverkusen | Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1985
- 1985-10-22 IT IT22578/85A patent/IT1190405B/it active
-
1986
- 1986-10-03 IL IL80229A patent/IL80229A0/xx not_active IP Right Cessation
- 1986-10-14 GR GR862546A patent/GR862546B/el unknown
- 1986-10-15 AR AR86305576A patent/AR243883A1/es active
- 1986-10-15 NO NO864108A patent/NO167570C/no unknown
- 1986-10-16 NZ NZ217964A patent/NZ217964A/en unknown
- 1986-10-20 EP EP86830300A patent/EP0223744B1/en not_active Expired - Lifetime
- 1986-10-20 DE DE8686830300T patent/DE3684244D1/de not_active Expired - Fee Related
- 1986-10-20 AT AT86830300T patent/ATE73453T1/de not_active IP Right Cessation
- 1986-10-20 ZA ZA867941A patent/ZA867941B/xx unknown
- 1986-10-20 ES ES8602677A patent/ES2002425A6/es not_active Expired
- 1986-10-21 IE IE276886A patent/IE58330B1/en not_active IP Right Cessation
- 1986-10-21 JP JP61251553A patent/JPH0772186B2/ja not_active Expired - Lifetime
- 1986-10-21 CA CA000520953A patent/CA1330994C/en not_active Expired - Fee Related
- 1986-10-21 FI FI864260A patent/FI89167C/fi not_active IP Right Cessation
- 1986-10-21 HU HU864363A patent/HU202863B/hu not_active IP Right Cessation
- 1986-10-21 TN TNTNSN86144A patent/TNSN86144A1/fr unknown
- 1986-10-22 PT PT83604A patent/PT83604B/pt not_active IP Right Cessation
- 1986-10-22 EG EG662/86A patent/EG18109A/xx active
- 1986-10-22 AU AU64273/86A patent/AU596382B2/en not_active Ceased
- 1986-10-22 PH PH34400A patent/PH22766A/en unknown
- 1986-10-22 US US06/921,397 patent/US4806534A/en not_active Expired - Fee Related
- 1986-10-22 DK DK506386A patent/DK169408B1/da not_active IP Right Cessation
- 1986-10-22 KR KR1019860008836A patent/KR910009269B1/ko not_active IP Right Cessation
- 1986-10-22 CN CN198686107544A patent/CN86107544A/zh active Pending
-
1992
- 1992-05-23 SG SG551/92A patent/SG55192G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3685608D1 (de) | 8-phenylxanthine. | |
| FI860982A0 (fi) | Katjoniska ympade staerkelsekopolymerer. | |
| FI860088A (fi) | Foerfarande foer katalysatordeaktivering. | |
| FI860877A0 (fi) | Silanordning. | |
| FI863114A0 (fi) | En pappersmaskins inloppslaoda. | |
| DE3673520D1 (de) | Perfluorpolyaether. | |
| FI863076A0 (fi) | Kontaktanordning. | |
| FI850890A0 (fi) | Kyvettserie foer blodundersoekning. | |
| FI864260A (fi) | Flavonderivat. | |
| FI860201A0 (fi) | Vaermebatteri. | |
| FI864347A0 (fi) | Foer bredbandssignaler avsedd rumskopplingsanordning. | |
| FI861919A0 (fi) | Kompressoranordning. | |
| FI864211A (fi) | Elektrolyscell. | |
| FI860404A0 (fi) | Ljudsyntetisatormodul. | |
| FI864374A (fi) | Brotsch. | |
| FI863584A0 (fi) | Elektrisk utfaellningselektrod. | |
| FI863170A (fi) | Rektala doseringsformer. | |
| FI850575L (fi) | Aokdon. | |
| FI860529A (fi) | Inmatnings- och indikeringsanordning foer bordscentrifugers driftparametrar. | |
| FI863219A0 (fi) | Framstaellningsfoerfarande foer djup- och flexotryckfaerger. | |
| FI870735A (fi) | Roentgenstraoldetektor. | |
| FI850220A0 (fi) | Skivpress. | |
| FI863224A (fi) | Saekerhetsarrangemang foer en klocksignal. | |
| FI860806A0 (fi) | Madrasserad passagerarsits. | |
| FI864689A0 (fi) | Traehus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: RECORDATI S.A., CHEMICAL AND |